Enzymotec Overview

  • Founded
  • 1998
  • Status
  • Acquired/​Merged
  • Employees
  • 235
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $270M
Latest Deal Amount

Enzymotec General Information


Producer and seller of lipid-based bioactive ingredients created to offer medical foods based on sophisticated processes and technologies. The company's lipid-based bioactive ingredients are used in a wide range of products, including a drugs for reducing cholesterol and the treatment of attention disorders and slowing cognitive degeneration in adults, as well as nutritional supplements, enabling the nutritional supplement, healthcare, medical foods and infant formula industries avail advanced products in order to produce infant food and nutritional supplements.

Contact Information

Ownership Status
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Other Consumer Non-Durables
Other Industries
Other Pharmaceuticals and Biotechnology
Parent Company
Primary Office
  • P.O. Box 6
  • Migdal Ha'Emeq 2310001
  • Israel
+972 000-000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Enzymotec Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Merger/Acquisition 20-Dec-2017 $270M 0000 00000 Completed Profitable
8. Secondary Transaction - Open Market 24-Aug-2017 000.00 0000 00000 Completed Profitable
7. Secondary Transaction - Open Market 09-Feb-2016 0000 Completed Profitable
6. Secondary Transaction - Open Market 05-Mar-2014 00000 0000 00000 Completed Profitable
5. IPO 27-Sep-2013 000.00 0000 00.000 Completed Profitable
4. PE Growth/Expansion 000.00 Completed Generating Revenue
3. Early Stage VC (Series B1) 02-Feb-2009 000.00 000.00 Completed Generating Revenue
2. Early Stage VC 20-Jun-2001 $2M $3M 000.00 Completed Product Development
1. Early Stage VC 01-Jan-2000 $1M $1M 000 Completed Product Development
To view Enzymotec’s complete valuation and funding history, request access »

Enzymotec Comparisons

HQ Location
Total Raised
Post Valuation
Last Financing Details
Producer and seller of lipid-based bioactive ingredients created to offer medical foods based on sophisticated processes
Other Consumer Non-Durables
Migdal Ha'Emeq, Israel
235 As of 2017
0000 0000-00-00
000000&0 0000


amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqu
Waukegan, IL
00 As of 0000
000000000000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Enzymotec Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
0000000000 Private Equity-Backed Waukegan, IL 00 00.000 000000000000 00.000
You’re viewing 1 of 1 competitors. Get the full list »

Enzymotec Executive Team (13)

Name Title Board Seat Contact Info
Dror Israel Chief Financial Officer & Vice President
Oren Bryan Vice President & Chief Financial Officer
Efrat Manoff Chief Operating Officer & Vice President
Basheer Sobhi Ph.D Co-Founder
Daniel Plotkin Co-Founder
You’re viewing 5 of 13 executive team members. Get the full list »

Enzymotec Board Members (7)

Name Representing Role Since
Dov Pekelman Ph.D Self Independent Director 000 0000
Steve Dubin JD Self Independent Chairman 000 0000
Yossi Peled Self Board Member 000 0000
You’re viewing 3 of 7 board members. Get the full list »

Enzymotec Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Enzymotec Former Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Arancia Corporation Minority 000 0000 000000 0
Galam PE-Backed Company Minority 000 0000 000000 0
GlenRock Israel Venture Capital Minority 000 0000 000000 0
Millennium Materials Technologies Fund Venture Capital Minority 000 0000 000000 0
SICAR Growth/Expansion Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »

Enzymotec Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 (000000 30-Aug-2017 000000000 00000 00 Buildings and Property 0000 0000000
Advanced Lipids 26-Jun-2007 Joint Venture Food Products
To view Enzymotec’s complete investments history, request access »